Featured Precision Medicine Videos |view more
David C. Fajgenbaum, MD, MBA, MSc, describes his experience with refractory idiopathic multi centric Castleman’s Disease (iMCD).
Sara Cherry, PhD, reviews ongoing research at the Penn Center for Precision Medicine to develop a personalized approach to acute myeloid leukemia.
Henry R. Kranzler, MD, examines efforts at the Penn Center for Precision Medicine to develop a genetic index of opioid sensitivity personalized to individuals at risk.
Terence P. Gade, MD, PhD, describes research at the Penn Center for Precision Medicine aimed at adding to the drug armamentarium for liver cancer.
Aimee S. Payne, MD, PhD, describes pemphigus, a rare autoimmune blistering disorder, and the targeted CAR-T cell directed immunotherapy being developed to control it at Penn Medicine.
Genevieve P. Kanter, PhD, describes the link in her research between economic analysis and precision medicine.
Tracey Evans, MD, explains that understanding cancer genetics has led to advanced targeted therapies and the advent of genomic profiling.
Robert Babak Faryabi, PhD, describes using artificial intelligence to develop algorithms to detect and interpret the effects of complex mutations in the cancer genome.
Daniel S. Herman, MD, PhD, discusses efforts at the Penn Center for Precision Medicine to create a dynamic automated system that will collate and interpret a patient’s medical record in real time.
Kim A. Reiss Binder, MD, describes a therapeutic approach in Phase 2 clinical trials at the Penn Center for Precision Medicine for patients with pancreatic cancer.
Penn Medicine News